Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Randomized, Double-Blind, Placebo Controlled Phase 3 Clinical Trial to Evaluate Efficacy and Safty of Mesenchymal Stem Cells JointStem in Patients With Knee Osteoarthritis

NCT03990805 is registered in ClinicalTrials.gov with R-Bio as lead sponsor.

NCT NCT03990805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03990805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Randomized, Double-Blind, Placebo Controlled Phase 3 Clinical Trial to Evaluate Efficacy and Safty of Mesenchymal Stem Cells JointStem in Patients With Knee Osteoarthritis
Lead sponsor
R-Bio
Phase
Phase 3
Overall status
Completed
Start date
June 11, 2019
Completion date
December 15, 2020
Enrollment
260 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative arthritis, knee osteoarthritis